BioSpace News Archive

TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP), today announced that it has received a follow-on order from ITH Pharma Limited (ITH)

Industry leader in dental waste management and regulation compliance will build upon strong foundation while empowering continued growth, expansion, and diversification

EVERSANA ™, the pioneer of next-generation commercial services to the life sciences industry, and Experic , a contract manufacturing organization (CMO) and pharmaceutical supply service company, today announced a collaboration to optimize clinical development, manufacturing, launch planning and commercialization efforts

GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for the treatment of adult patients with active lupus nephritis (LN) who are receiving standard therapy. Lupus nephritis is a seriou

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today filing of an Investigational New Drug (IND) application seeking permission from the Food and Drug Administration (FDA) to initiate a Phase I/II clinical trial assessing safety and signals of efficacy for treatment of Chronic Traumatic Encephalopathy

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that the Investigational New Drug (IND) application for its lead product candidate, Berubicin,

Ginkgo Bioworks, Azitra, Inc., Florida International University, and Latham BioPharm Group have been awarded a contract by the Defense Advanced Research Projects Agency for up to $15M, as part of its ReVector program.

Activ Surgical™, a digital surgery pioneer, announced the appointment of Heather Mannila as Vice President of Finance.

Allterum Therapeutics, Inc. completed its $1.8 million Series Seed offering to members of the FanninDirect SM investor group. Allterum is developing a novel immunotherapy for treatment of IL7R-expressing cancers, including difficult to treat cases of pediatric acute lymphoblastic leukemia (ALL), a program which has received both Orph

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of its Systematic HLA Epitope Ranking Pan Algorithm (SHERPA), the company’s proprietary, machine learning-based tool for the comprehensive identification and characterization of cancer neoantigens. Integrated into the Personalis® NeXT Platform™, SHERPA enables the development of new neoantigen-based diagnostic biomark